CD4 and systemic lupus erythematosus: We, therefore, explored whether naive CD4+ T cells from SLE patients have a similar increase in ORAI3 and decrease in IKAROS transcripts as those from RA and PsA patients; however, we did not observe a decline in SLE T cells.